Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
you are here: HomeNewsBusiness
Jan 10, 2018 05:00 PM IST | Source: PTI

Lupin gets USFDA nod for generic version of Tamiflu capsules

The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc's Tamiflu capsules.

Drug major Lupin said it has received approval from the US Food and Drug Administration (USFDA) to market a generic version of Tamiflu capsules, used in treating influenza.

The company has received final approval from the US drug regulator to market oseltamivir phosphate capsules, a generic version of Hoffman-La Roche Inc's Tamiflu capsules in strengths of 30 mg, 45 mg, and 75 mg, Lupin said in a statement.

Oseltamivir phosphate capsules are indicated for the treatment of influenza.

As per IMS MAT October 2017 data, the capsules clocked annual sales of around USD 467.8 million in the US market.

Shares of Lupin closed 0.46 per cent up at Rs 925.05 on the BSE.
Sections
Follow us on
Available On